CDT Positions for Transformational Growth
CDT Equity Inc. (CDT)
Company Research
Source: GlobeNewswire
NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 04, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) advances multiple initiatives designed to enhance shareholder value and expand its strategic footprint. The Company continues to actively develop and expand its pharmaceutical asset portfolio, including solid-form and cocrystal development programs, alongside its licensed clinical assets AZD1656, AZD5658 and AZD5904 under its agreement with AstraZeneca. CDT remains engaged in ongoing evaluation and out-licensing discussions and continues to assess pathways to maximize the commercial and strategic potential of these assets. The Company believes this diversified asset base provides several avenues through which value may be realized. In addition, CDT recently completed its strategic acquisition of a 20% equity stake in Sarborg for an initial consideration of $115 million, providing shareholders with direct participation in a growing agentic AI signatu
Show less
Read more
Impact Snapshot
Event Time:
CDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDT alerts
High impacting CDT Equity Inc. news events
Weekly update
A roundup of the hottest topics
CDT
News
- CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent [Yahoo! Finance]Yahoo! Finance
- CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature AgentGlobeNewswire
- CDT Equity Notes Sarborg Expansion into Bacteria and AgrochemicalsGlobeNewswire
- CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset StrategyGlobeNewswire
- CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing StrategyGlobeNewswire
CDT
Sec Filings
- 2/24/26 - Form 8-K
- 2/24/26 - Form PRE
- 2/23/26 - Form 4
- CDT's page on the SEC website